search
Back to results

Efficacy and Safety of Primary Teeth Anesthesia Using Nasal Spray in Children

Primary Purpose

Dental Caries

Status
Completed
Phase
Not Applicable
Locations
Syrian Arab Republic
Study Type
Interventional
Intervention
Nasal Spray of Lidocaine HCL
Infiltration injection of Lidocaine HCL
Sponsored by
Damascus University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dental Caries

Eligibility Criteria

7 Years - 10 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Healthy children between 7-10 years.
  2. With a need for pulpotomy or a restorative dental procedure requiring local anesthesia for a single vital primary maxillary second molar with no evidence of pulpal necrosis.
  3. Normal lip, nose, eyelid, and cheek sensation.
  4. No history of allergy for lidocaine-hydrochloride or epinephrine-hydrochloride.

Exclusion Criteria:

  1. Frequent bleeding form the nose (≥ 5 per month)
  2. Inadequately controlled active thyroid disease of any type.
  3. Having received dental care requiring a local anesthetic within the 24 hours preceding study entry.
  4. History of allergy to or intolerance of lidocaine or epinephrine.

Sites / Locations

  • Department of Peadodontics, University of Damascus Dental School

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Nasal Spray of Lidocaine HCL

Infiltration injection of Lidocaine HCL

Arm Description

This group will receive treatment with an application of nasal spray for anesthetization.

Each patient in this group will receive an infiltration injection for anesthetization

Outcomes

Primary Outcome Measures

Change in Blood Pressure
Systolic and diastolic blood pressure will be measured.
Change in Oxygen Saturation
Oxygen saturation will be measured using a specific device.
Change in Respiration Rate
Respiration rate will be measured clinically in the conventional manner.
Change in Heart Pulse Rate
Heart pulse rate will be measured clinically in the conventional manner.
Change in FLACC scale
This scale will be used to evaluate efficacy. It will be studied by an external observer at 5 stages; first stage: during administration of the drug, second stage: while probing the gingiva around the tooth "buccally, palatally", third stage: when penetration of the dentino-enamel junction occurs, fourth stage: when exposure of the dental pulp occurs, fifth stage: during the removal of the coronal pulp.
Change in Frankl scale
This scale will be used to evaluate children's acceptance and will be measured by an external observer at five assessment times.

Secondary Outcome Measures

Full Information

First Posted
April 14, 2017
Last Updated
July 26, 2017
Sponsor
Damascus University
search

1. Study Identification

Unique Protocol Identification Number
NCT03140787
Brief Title
Efficacy and Safety of Primary Teeth Anesthesia Using Nasal Spray in Children
Official Title
Assessment of Efficacy and Safety of Primary Maxillary Second Molars Anesthesia Using Nasal Spray in Children
Study Type
Interventional

2. Study Status

Record Verification Date
July 2017
Overall Recruitment Status
Completed
Study Start Date
May 15, 2016 (Actual)
Primary Completion Date
May 15, 2017 (Actual)
Study Completion Date
June 15, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Damascus University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
68 healthy children from the Department of Pediatric Dentistry at Damascus University who require treatment for their primary maxillary second molars will be randomly assigned into one of two groups: experimental or control groups. In the experimental group, a lidocaine hydrochloride-epinephrine hydrochloride nasal spray will be applied to anesthetize upper second molar before the commencement of treatment. To assess the efficacy of this kind of anesthesia, a specific scale will be used by an external observer after capturing some video files of the performed treatment. To assess the safety of this procedure, vital signs will be recorded before and after treatment. Acceptance of the nasal spray will be recorded based on the child's behavior before and after treatment using Frankl scale. If anesthesia was not sufficient to proceed with the procedure, a rescue anesthesia would be used. Rescue anesthesia consists of an infiltration injection of lidocain hydrochloride 2% with epinephrine hydrochloride (1:100,000). In the control group, an intra-oral lidocaine-epinephrine injection will be applied due to treatment. Safety, efficacy and acceptance will be assessed in the same manner to what is performed in the experimental group.
Detailed Description
The most common method for anesthetizing maxillary teeth is infiltration injection of an anesthetic agent. This approach carries several disadvantages. First is the child's fear of pain. Infection is also a risk for providers, through exposure to blood-borne pathogens via needle stick. Fear of a painful dental injection and subsequent avoidance behavior are significant barriers to regular visits to the dentist. Importantly, patients' fear of injections can delay needed dental care. Surveys indicate that 30-40 million people in the US avoid going to the dentist because of fear of pain and anesthetic injections. Therefore an anesthetic procedure that would avoid the discomfort of a local anesthetic injection thus obviating fear and anxiety about receiving a "shot," would greatly benefit dental patients. Further, for procedures involving more than one maxillary tooth on the same side, a trans-nasally applied anesthetic agent that could anesthetize multiple maxillary teeth at once instead of use of repeated infiltration injections would be a major convenience for patients and dentists.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Caries

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
68 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Nasal Spray of Lidocaine HCL
Arm Type
Experimental
Arm Description
This group will receive treatment with an application of nasal spray for anesthetization.
Arm Title
Infiltration injection of Lidocaine HCL
Arm Type
Active Comparator
Arm Description
Each patient in this group will receive an infiltration injection for anesthetization
Intervention Type
Drug
Intervention Name(s)
Nasal Spray of Lidocaine HCL
Intervention Description
This spray consists of lidocaine hydrochloride-epinephrine hydrochloride
Intervention Type
Drug
Intervention Name(s)
Infiltration injection of Lidocaine HCL
Intervention Description
This is the ordinary method of establishing anesthesia for patients undergoing dental treatment for caries.
Primary Outcome Measure Information:
Title
Change in Blood Pressure
Description
Systolic and diastolic blood pressure will be measured.
Time Frame
(1) five minutes before drug administration, (2) after 10 minutes of anesthesia, and (3) at the completion of the dental treatment, an average of 40 minutes.
Title
Change in Oxygen Saturation
Description
Oxygen saturation will be measured using a specific device.
Time Frame
(1) five minutes before drug administration, (2) after 10 minutes of anesthesia, and (3) at the completion of the dental treatment, an average of 40 minutes.
Title
Change in Respiration Rate
Description
Respiration rate will be measured clinically in the conventional manner.
Time Frame
(1) five minutes before drug administration, (2) after 10 minutes of anesthesia, and (3) at the completion of the dental treatment, an average of 40 minutes.
Title
Change in Heart Pulse Rate
Description
Heart pulse rate will be measured clinically in the conventional manner.
Time Frame
(1) five minutes before drug administration, (2) after 10 minutes of anesthesia, and (3) at the completion of the dental treatment, an average of 40 minutes.
Title
Change in FLACC scale
Description
This scale will be used to evaluate efficacy. It will be studied by an external observer at 5 stages; first stage: during administration of the drug, second stage: while probing the gingiva around the tooth "buccally, palatally", third stage: when penetration of the dentino-enamel junction occurs, fourth stage: when exposure of the dental pulp occurs, fifth stage: during the removal of the coronal pulp.
Time Frame
(1) within the first minute of drug administration, (2) when probing the gingiva at approx. Minute 5, (3) when entering the dentin at approx. Minute 10, (4) when exposing the pulp at approx. Minute 15, (5) during the removal of the pulp at Minute 20
Title
Change in Frankl scale
Description
This scale will be used to evaluate children's acceptance and will be measured by an external observer at five assessment times.
Time Frame
(1) within the first minute of drug administration, (2) when probing the gingiva at approx. Minute 5, (3) when entering the dentin at approx. Minute 10, (4) when exposing the pulp at approx. Minute 15, (5) during the removal of the pulp at Minute 20

10. Eligibility

Sex
All
Minimum Age & Unit of Time
7 Years
Maximum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Healthy children between 7-10 years. With a need for pulpotomy or a restorative dental procedure requiring local anesthesia for a single vital primary maxillary second molar with no evidence of pulpal necrosis. Normal lip, nose, eyelid, and cheek sensation. No history of allergy for lidocaine-hydrochloride or epinephrine-hydrochloride. Exclusion Criteria: Frequent bleeding form the nose (≥ 5 per month) Inadequately controlled active thyroid disease of any type. Having received dental care requiring a local anesthetic within the 24 hours preceding study entry. History of allergy to or intolerance of lidocaine or epinephrine.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mohammad Raslan Alzein, DDS
Organizational Affiliation
MSc student, Department of Paedodontics, University of Damascus Dental School
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Shadi Azzawi, DDS MSc PhD
Organizational Affiliation
Senior Lecturer in Paedodontics, Department of Paedodontics, University of Damascus Dental School, Damascus, Syria
Official's Role
Study Director
Facility Information:
Facility Name
Department of Peadodontics, University of Damascus Dental School
City
Damascus
ZIP/Postal Code
DM20AM18
Country
Syrian Arab Republic

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23690356
Citation
Ciancio SG, Hutcheson MC, Ayoub F, Pantera EA Jr, Pantera CT, Garlapo DA, Sobieraj BD, Almubarak SA. Safety and efficacy of a novel nasal spray for maxillary dental anesthesia. J Dent Res. 2013 Jul;92(7 Suppl):43S-8S. doi: 10.1177/0022034513484334. Epub 2013 May 20.
Results Reference
background
PubMed Identifier
23050753
Citation
Reed KL, Malamed SF, Fonner AM. Local anesthesia part 2: technical considerations. Anesth Prog. 2012 Fall;59(3):127-36; quiz 137. doi: 10.2344/0003-3006-59.3.127.
Results Reference
background
PubMed Identifier
22900449
Citation
Pandey RK, Bahetwar SK, Saksena AK, Chandra G. A comparative evaluation of drops versus atomized administration of intranasal ketamine for the procedural sedation of young uncooperative pediatric dental patients: a prospective crossover trial. J Clin Pediatr Dent. 2011 Fall;36(1):79-84. doi: 10.17796/jcpd.36.1.1774746504g28656.
Results Reference
background
PubMed Identifier
26822100
Citation
Hersh EV, Pinto A, Saraghi M, Saleh N, Pulaski L, Gordon SM, Barnes D, Kaplowitz G, Bloom I, Sabti M, Moore PA, Lee S, Meharry M, He DY, Li Y. Double-masked, randomized, placebo-controlled study to evaluate the efficacy and tolerability of intranasal K305 (3% tetracaine plus 0.05% oxymetazoline) in anesthetizing maxillary teeth. J Am Dent Assoc. 2016 Apr;147(4):278-87. doi: 10.1016/j.adaj.2015.12.008. Epub 2016 Jan 25.
Results Reference
background
PubMed Identifier
22341059
Citation
Kanaa MD, Whitworth JM, Meechan JG. A comparison of the efficacy of 4% articaine with 1:100,000 epinephrine and 2% lidocaine with 1:80,000 epinephrine in achieving pulpal anesthesia in maxillary teeth with irreversible pulpitis. J Endod. 2012 Mar;38(3):279-82. doi: 10.1016/j.joen.2011.11.010. Epub 2011 Dec 22.
Results Reference
background
PubMed Identifier
22414822
Citation
Kanaa MD, Whitworth JM, Meechan JG. A prospective randomized trial of different supplementary local anesthetic techniques after failure of inferior alveolar nerve block in patients with irreversible pulpitis in mandibular teeth. J Endod. 2012 Apr;38(4):421-5. doi: 10.1016/j.joen.2011.12.006. Epub 2012 Feb 2.
Results Reference
background

Learn more about this trial

Efficacy and Safety of Primary Teeth Anesthesia Using Nasal Spray in Children

We'll reach out to this number within 24 hrs